Administrative Core-Interdisciplinary Ctr for Male Contraceptive Res & Drug Dev
Administrative Core-Interdisciplinary Ctr for Male Contraceptive Res & Drug Dev
批准号:
8066368
负责人:
JOSEPH S TASH
金额:
$44.28万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2012-02-29
关键词:
AreaBiologicalBiomedical ResearchChemicalsClinical PharmacologyCommunicationContractsCore FacilityDataDatabasesDevelopmentDoctor of PharmacyDoctor of PhilosophyEnsureEnvironmentEquipmentFamilyFloorFoundationsFunding AgencyGiftsGrantHeadHormonalHousingImageIndividualInternetKansasLaboratoriesLeadLocationMale Contraceptive AgentsMedical centerMinnesotaNational Institute of Child Health and Human DevelopmentOnline SystemsPharmaceutical PreparationsPrincipal InvestigatorProceduresRegulationResearchResearch PersonnelResearch Project GrantsResearch SupportRestScheduleScienceSecureTestingTherapeuticTravelUnited States National Institutes of HealthUniversitiescostdesigndrug developmentdrug discoveryinnovationmedical schoolsmeetingsreproductivesquare footsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary of space allocated for the U54 Interdisciplinary Center for Male Contraceptive Research
and Drug Discovery:
New Biomedical Research Center (BRC) will house all U54 Research Project Principal Investigators
and two support Core Units. The University of Kansas Medical Center will complete construction of a new
$52 million research building containing 179,582 Net Assignable Square Feet (NASF). Occupancy of this building
is schedule to begin in October, 2006 and be completed by December, 2006 and will include laboratory, office,
and research support space for all of the U54 Research Project Principal Investigators as well as the Administrative
and Imaging Cores of the U54 Center. These will all be located on the 33,294 square foot 3rd floor
of the BRC (see Figure 1, next page). This floor will also be occupied by both the Interdisciplinary Center for
Male Contraceptive Research and Drug Development and the Center for Reproductive Sciences, and thus
represents a highly interactive, collaborative, and supportive environment for conducting the research on male
contraceptive development. The individual labs in the BRC will be well equipped; there are no requests for
equipment since the university has provided new equipment for all labs associated with this U54. Where appropriate,
investigators have centralized equipment from their own labs into the core in order to reduce duplication
and costs. However, most of the equipment in the cores (laboratories and administrative) was provided by
the Dean's office of the School of Medicine and by matching of previous NIH grants. In addition, a $27 million
gift from the Hall Family Foundation to the University of Kansas Medical Center provided for the purchase of
new and replacement equipment for all of the investigators and cores moving into the BRC.
The Drug, Discovery, Design & Synthesis Core (DDS Core) is housed in facilities at the University of
Kansas-Lawrence and at the University of Minnesota. These are the same core facilities that are currently being
utilized in our multi-campus NICHD contract "Synthesis and Testing of Non-hormonal Non-Steroidal Male
Contraceptive Agents." The location of the facility at University of Kansas-Lawrence is about 30 miles from the
University of Kansas Medical Center. During the current and previous contract on male contraceptive development,
this distance provides no barrier to the smooth conduct of the research between the two campuses.
Due to OSHA regulations, compounds submitted by the Drug, Discovery, Design & Synthesis core to investigators
at University of Kansas Medical Center must be transported by commercial carriers (such as FEDEX overnight).
This procedure will continue in the U54 center, as well as between the facilities at the University of Minnesota
and the other campuses in the Center. Other administrative arrangements to ensure good communications
between the core components and the rest of the center include: 1) A secure web-based data repository
for chemical, physical, and biological data. 2) Drs. Tash, Georg, and Schonbrunn will be meet face-to-face at
least every six months (additional travel costs will be covered by alternate funding sources) to make sure the
core needs are being met smoothly. 3) Finally, all seminars and meetings involving center investigators will be
available by web video conference at both campuses.
The Drug Development Core (DD Core) is located in administrative space in facilities at both the University
of Kansas Medical Center and at the University of Kansas-Lawrence. This core is probably unique in an
academic center. The core is headed by Scott Weir, Pharm.D, Ph.D.. Dr. Weir's specific areas of expertise are
in clinical pharmacology and developing innovative approaches in lead optimization and early drug development.
Dr. Weir has developed drug products across a wide range of therapeutic areas. The DD Core facility at
KUMC is located across the street from the BRC, where the research project labs and Administrative and Imaging
cores are located.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell-cycle regulatory kinases as targets for male contraceptive drug development
-
批准号:8727232
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2014
-
负责人:JOSEPH S TASH
-
依托单位:
Cell-cycle regulatory kinases as targets for male contraceptive drug development
-
批准号:8850887
-
项目类别:
-
资助金额:$30.66万
-
财政年份:2014
-
负责人:JOSEPH S TASH
-
依托单位:
H2-Gamendazole analogues as reversible non-hormonal male contraceptive agents
-
批准号:8711611
-
项目类别:
-
资助金额:$3.63万
-
财政年份:2012
-
负责人:JOSEPH S TASH
-
依托单位:
H2-Gamendazole analogues as reversible non-hormonal male contraceptive agents
-
批准号:8889699
-
项目类别:
-
资助金额:$25.54万
-
财政年份:2012
-
负责人:JOSEPH S TASH
-
依托单位:
H2-Gamendazole analogues as reversible non-hormonal male contraceptive agents
-
批准号:8692993
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2012
-
负责人:JOSEPH S TASH
-
依托单位:
H2-Gamendazole analogues as reversible non-hormonal male contraceptive agents
-
批准号:8509840
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2012
-
负责人:JOSEPH S TASH
-
依托单位:
H2-Gamendazole analogues as reversible non-hormonal male contraceptive agents
-
批准号:8534230
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2012
-
负责人:JOSEPH S TASH
-
依托单位:
Novel Male Contraceptive Agents that Target HSP90 and Elongation Factor 1A
-
批准号:8066371
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2010
-
负责人:JOSEPH S TASH
-
依托单位:
Administrative Core-Interdisciplinary Ctr for Male Contraceptive Res & Drug Dev
-
批准号:7789621
-
项目类别:
-
资助金额:$10.89万
-
财政年份:2009
-
负责人:JOSEPH S TASH
-
依托单位:
Interdisciplinary Center for Male Contraceptive Research and Drug Development
-
批准号:7932578
-
项目类别:
-
资助金额:$13.64万
-
财政年份:2009
-
负责人:JOSEPH S TASH
-
依托单位:
Interdisciplinary Center for Male Contraceptive Research and Drug Development
-
批准号:8136761
-
项目类别:
-
资助金额:$112.45万
-
财政年份:2007
-
负责人:JOSEPH S TASH
-
依托单位:
Interdisciplinary Center for Male Contraceptive Research and Drug Development
-
批准号:7277492
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2007
-
负责人:JOSEPH S TASH
-
依托单位:
Interdisciplinary Center for Male Contraceptive Research and Drug Development
-
批准号:7578921
-
项目类别:
-
资助金额:$150.34万
-
财政年份:2007
-
负责人:JOSEPH S TASH
-
依托单位:
Interdisciplinary Center for Male Contraceptive Research and Drug Development
-
批准号:7789627
-
项目类别:
-
资助金额:$153.21万
-
财政年份:2007
-
负责人:JOSEPH S TASH
-
依托单位:
Interdisciplinary Center for Male Contraceptive Research and Drug Development
-
批准号:8066374
-
项目类别:
-
资助金额:$238.64万
-
财政年份:2007
-
负责人:JOSEPH S TASH
-
依托单位:
CORE--IMAGE ANALYSIS AND PHOTOGRAPHY
-
批准号:6316698
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2000
-
负责人:JOSEPH S TASH
-
依托单位:
CORE--IMAGE ANALYSIS AND PHOTOGRAPHY
-
批准号:6108828
-
项目类别:
-
资助金额:$10.81万
-
财政年份:1999
-
负责人:JOSEPH S TASH
-
依托单位:
CORE--IMAGE ANALYSIS AND PHOTOGRAPHY
-
批准号:6272388
-
项目类别:
-
资助金额:$10.39万
-
财政年份:1998
-
负责人:JOSEPH S TASH
-
依托单位:
CORE--IMAGE ANALYSIS AND PHOTOGRAPHY
-
批准号:6241351
-
项目类别:
-
资助金额:$9.75万
-
财政年份:1997
-
负责人:JOSEPH S TASH
-
依托单位:
PROTEIN PHOSPHORYLATION IN SPERM FLAGELLAR MOTILITY
-
批准号:3277138
-
项目类别:
-
资助金额:$1.96万
-
财政年份:1990
-
负责人:JOSEPH S TASH
-
依托单位:
海外基金